Lv2
110 积分 2023-06-25 加入
The landscape for radioligand therapies in oncology
16天前
已完结
To be GMP or not to be– a radionuclide’s question
2个月前
已完结
ICH M4Q指导原则实施的思考
2个月前
已完结
ICH M4E在中国实施的技术考虑
2个月前
已完结
CTD与eCTD的基本概念及在药品注册申报中的应用
2个月前
已完结
Regulation for the Bioequivalence Evaluation of Generic Topical Dermatological Drug Products in Japan
4个月前
已关闭
The 100th Monoclonal Antibody Product is Approved in Japan
4个月前
已关闭
Regulation for the Bioequivalence Evaluation of Generic Topical Dermatological Drug Products in Japan
4个月前
已关闭
The European Medicines Agency evaluation of nemolizumab (Nemluvio) for the treatment of moderate-to-severe atopic dermatitis and prurigo nodularis
4个月前
已关闭
Current Use of Physiologically-Based Pharmacokinetic (PBPK) Modeling in New Medicinal Product Approvals at EMA: A Clinical Appraisal of Voclosporin in Lupus Nephritis
4个月前
已完结
皖公网安备34019202002308
